Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
Victoria P. Werth, Richard Furie, Juanita Romero‐Díaz, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 4, pp. 321-331
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
Richard Furie, Ronald van Vollenhoven, Kenneth Kalunian, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 10, pp. 894-904
Open Access | Times Cited: 76
Systemic lupus erythematosus: one year in review 2023
Dina Zucchi, Ettore Silvagni, Elena Elefante, et al.
Clinical and Experimental Rheumatology (2023)
Open Access | Times Cited: 44
Myeloid C-type lectin receptors in innate immune recognition
Caetano Reis e Sousa, Sho Yamasaki, Gordon D. Brown
Immunity (2024) Vol. 57, Iss. 4, pp. 700-717
Open Access | Times Cited: 26
Vascular damage in systemic lupus erythematosus
William G Ambler, Mariana J. Kaplan
Nature Reviews Nephrology (2024) Vol. 20, Iss. 4, pp. 251-265
Closed Access | Times Cited: 21
Advances in the management of systemic lupus erythematosus
Eric F. Morand, Ruth Fernandez‐Ruiz, Ashira Blazer, et al.
BMJ (2023), pp. e073980-e073980
Open Access | Times Cited: 40
IRF7: role and regulation in immunity and autoimmunity
W. F. Mader, Gang Huang, Zhi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 37
New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review
Renaud Felten, Marc Scherlinger, Philippe Mertz, et al.
Joint Bone Spine (2023) Vol. 90, Iss. 2, pp. 105523-105523
Open Access | Times Cited: 34
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
Dennis Niebel, Luka de Vos, Tanja Fetter, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 4, pp. 521-540
Open Access | Times Cited: 33
Targeting type I interferons in systemic lupus erythematous
Sebastian Bruera, Thandiwe Chavula, Riya Madan, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 22
The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond
Clémence Ngo, Clémence Garrec, Elena Tomasello, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 9, pp. 1008-1035
Open Access | Times Cited: 13
Immunopathogenesis of systemic lupus erythematosus: An update
Laurent Arnaud, François Chasset, Thierry Martin
Autoimmunity Reviews (2024) Vol. 23, Iss. 10, pp. 103648-103648
Closed Access | Times Cited: 11
Emerging biologic therapies for systemic lupus erythematosus
Hiroshi Kato, J. Michelle Kahlenberg
Current Opinion in Rheumatology (2024) Vol. 36, Iss. 3, pp. 169-175
Closed Access | Times Cited: 8
An update on clinical trials for cutaneous lupus erythematosus
Lillian Xie, Laís Lopes Almeida Gomes, Caroline J. Stone, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 7, pp. 885-894
Open Access | Times Cited: 8
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response
Ana Carolina Londe, Ruth Fernandez‐Ruiz, Paulo Rogério Júlio, et al.
The Journal of Rheumatology (2023) Vol. 50, Iss. 9, pp. 1103-1113
Open Access | Times Cited: 19
NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 17
Novel and potential future therapeutic options in systemic autoimmune diseases
Lili Balogh, Katalin Oláh, Soma Sánta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Clinical trial outcomes for SLE: what we have and what we need
Laurent Arnaud, Ioannis Parodis, H. Devilliers, et al.
Lupus Science & Medicine (2024) Vol. 11, Iss. 1, pp. e001114-e001114
Open Access | Times Cited: 5
Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE
Eduardo Gómez-Bañuelos, Daniel Goldman, Victoria Soledad Andrade, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101569-101569
Open Access | Times Cited: 5
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned
Sarah A. Jones, Eric F. Morand
Drugs (2024) Vol. 84, Iss. 6, pp. 625-635
Open Access | Times Cited: 5
Ontogeny and Function of Plasmacytoid Dendritic Cells
Nicholas M. Adams, Annesa Das, Tae Jin Yun, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 347-373
Closed Access | Times Cited: 5
Altered X-chromosome inactivation of the TLR7/8 locus and heterogeneity of pDCs in systemic sclerosis
Yong Du, Bérénice Faz-Lopez, Marie Dominique Ah Kioon, et al.
The Journal of Experimental Medicine (2024) Vol. 222, Iss. 3
Closed Access | Times Cited: 5
Ultraviolet B Induces Cutaneous Lupus Erythematosus by Triggering a Ribotoxic-Stress-Response-Dependent MIF-p38 Feedback Loop in Keratinocytes
Chipeng Guo, Siweier Luo, Jigang Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Novel therapies in SLE treatment: A literature review
Jakub Mastalerz, Alicja Dąbrowska, Wojciech Plizga, et al.
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
A focused report on IFN-1 targeted therapies for lupus erythematosus
Ankeet S. Bhatt, Pooja Gupta, Richard Furie, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-9
Closed Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top